KR

Kalpana Rai

Active Director Director DIN 09403778
DIN 09403778 First appointment Nov 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2021
Shareholding value Locked Premium profile

About Kalpana Rai

Kalpana Rai has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Stuk Medi Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09403778
Primary Designation Director
First Appointment 17 Nov 2021
Oldest Company Age 5 yrs

Current companies

Company Designation Appointment Founded Status
Stuk Medi Pharma Private Limited U33309BR2021PTC051295
Director 17 Nov 2021 2021 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Stuk Medi Pharma Private Limited
Premium access

Shareholding and investment profile for Kalpana Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalpana Rai

Kalpana Rai has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Stuk Medi Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Kalpana Rai is associated with 1 company as Director.

Kalpana Rai has expertise in General Business.

Kalpana Rai has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available